Assignee
NPS PHARMA INC
US·74 granted patents·29 pending applications·2,089 citations·filing 1993–2016
Top patents by PatentIndex Score
103 records- 0198US9545434B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2015·Granted Jan 17, 2017·38 cites·23 claims
- 0298US7847061B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2005·Granted Dec 7, 2010·58 cites·18 claims
- 0398US6660753B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2002·Granted Dec 9, 2003·160 cites·58 claims
- 0497US5589351AFluorescence detection apparatusNPS PHARMA INC·Filed 1994·Granted Dec 31, 1996·180 cites·21 claims
- 0596US6211244B1Calcium receptor-active compoundsNPS PHARMA INC·Filed 1995·Granted Apr 3, 2001·251 cites·46 claims
- 0694US6429207B1Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseasesNPS PHARMA INC·Filed 2000·Granted Aug 6, 2002·67 cites·23 claims
- 0793US6031003ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Feb 29, 2000·151 cites·145 claims
- 0891US6313146B1Calcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Nov 6, 2001·104 cites·55 claims
- 0990US7642241B2Methods of enhancing functioning of the large intestineNPS PHARMA INC·Filed 2007·Granted Jan 5, 2010·8 cites·9 claims
- 1090US6383527B1Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAIDNPS PHARMA INC·Filed 1999·Granted May 7, 2002·117 cites·39 claims
- 1189US6001884ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Dec 14, 1999·100 cites·44 claims
- 1289US5981599AInorganic ion receptor active compoundsNPS PHARMA INC·Filed 1997·Granted Nov 9, 1999·70 cites·27 claims
- 1387US6071970ACompounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesNPS PHARMA INC·Filed 1995·Granted Jun 6, 2000·66 cites·185 claims
- 1486US5648541AChiral reductions of imines leading to the syntheses of optically active aminesNPS PHARMA INC·Filed 1995·Granted Jul 15, 1997·34 cites·20 claims
- 1585US6750255B2Calcium receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Jun 15, 2004·19 cites·31 claims
- 1685US5504253AAmine preparationNPS PHARMA INC·Filed 1994·Granted Apr 2, 1996·18 cites·20 claims
- 1784US7235258B1Sustained-release formulations for treating CNS-mediated disordersNPS PHARMA INC·Filed 2000·Granted Jun 26, 2007·17 cites·8 claims
- 1884US7109238B2Calcilytic compoundsNPS PHARMA INC·Filed 2004·Granted Sep 19, 2006·13 cites·6 claims
- 1983US7074809B2CompoundsNPS PHARMA INC·Filed 2003·Granted Jul 11, 2006·23 cites·12 claims
- 2083US6362231B1Calcium receptor active compoundsNPS PHARMA INC·Filed 1997·Granted Mar 26, 2002·45 cites·30 claims
- 2182US7888317B2Glucagon-like peptide-2 and its therapeutic useNPS PHARMA INC·Filed 2006·Granted Feb 15, 2011·3 cites·4 claims
- 2282US7202261B2Calcilytic compoundsNPS PHARMA INC·Filed 2004·Granted Apr 10, 2007·13 cites·31 claims
- 2382US6818660B2Calcilytic compoundsNPS PHARMA INC·Filed 2001·Granted Nov 16, 2004·14 cites·15 claims
- 2482US6022894AMethod of using calcilytic compoundsNPS PHARMA INC·Filed 1997·Granted Feb 8, 2000·51 cites·30 claims
- 2581US7749543B2Methods useful in the treatment of bone resorption diseasesNPS PHARMA INC·Filed 2009·Granted Jul 6, 2010·3 cites·9 claims
- 2680US7053104B2Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseasesNPS PHARMA INC·Filed 2002·Granted May 30, 2006·9 cites·23 claims
- 2779US6939895B2Calcium receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Sep 6, 2005·10 cites·20 claims
- 2878US5962314ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1997·Granted Oct 5, 1999·50 cites·36 claims
- 2977US7781567B2Method for enzymatic production of GLP-2(1-33) and GLP-2(1-34) peptidesNPS PHARMA INC·Filed 2004·Granted Aug 24, 2010·4 cites·38 claims
- 3077US6796967B2Injection needle assemblyNPS PHARMA INC·Filed 2001·Granted Sep 28, 2004·91 cites·30 claims
- 3177US6710088B2Inorganic ion receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Mar 23, 2004·8 cites·26 claims
- 3274US6617358B1Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their usesNPS PHARMA INC·Filed 2000·Granted Sep 9, 2003·7 cites·19 claims
- 3373US9592273B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Mar 14, 2017·0 cites·8 claims
- 3473US9572867B2Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Feb 21, 2017·0 cites·8 claims
- 3573US9555079B1Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Jan 31, 2017·0 cites·8 claims
- 3673US9545435B1Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Jan 17, 2017·0 cites·17 claims
- 3773US9539310B1Treatment of short bowel syndrome patients with colon-in-continuityNPS PHARMA INC·Filed 2016·Granted Jan 10, 2017·0 cites·12 claims
- 3873US6589994B1Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compoundNPS PHARMA INC·Filed 1999·Granted Jul 8, 2003·27 cites·1 claims
- 3973US6432656B1Calcilytic compoundsNPS PHARMA INC·Filed 1999·Granted Aug 13, 2002·41 cites·9 claims
- 4071US7262280B1G-protein fusion receptors and constructs encoding sameNPS PHARMA INC·Filed 2000·Granted Aug 28, 2007·4 cites·28 claims
- 4171US6521667B1Calcilytic compoundsNPS PHARMA INC·Filed 1998·Granted Feb 18, 2003·28 cites·12 claims
- 4271US5981195AChimeric receptors and methods for identifying compounds active at metabotropic glutamate receptorsNPS PHARMA INC·Filed 1996·Granted Nov 9, 1999·17 cites·48 claims
- 4369US6342532B1Inorganic ion receptor active compoundsNPS PHARMA INC·Filed 1999·Granted Jan 29, 2002·22 cites·21 claims
- 4466US5506268AUse of isovaleramide as a mild anxiolytic and sedative agentNPS PHARMA INC·Filed 1993·Granted Apr 9, 1996·15 cites·15 claims
- 4565US5688764AInsecticidal peptides from spider venomNPS PHARMA INC·Filed 1995·Granted Nov 18, 1997·15 cites·38 claims
- 4664US7781401B2Glucagon-like peptide-2 analogsNPS PHARMA INC·Filed 2002·Granted Aug 24, 2010·0 cites·16 claims
- 4763US2014256632A1Methods useful in the treatment of bone resorption diseasesNPS PHARMA INC·Filed 2014·Application pending·0 cites
- 4862US7829307B2Production of glucagon-like peptide 2NPS PHARMA INC·Filed 2004·Granted Nov 9, 2010·2 cites·4 claims
- 4961US8846625B2Glucagon-like peptide-2 analogsNPS PHARMA INC·Filed 2013·Granted Sep 30, 2014·0 cites·13 claims
- 5060US8980567B2Ex vivo method for determining potential GLP-2 receptor modulatorsNPS PHARMA INC·Filed 2013·Granted Mar 17, 2015·0 cites·16 claims
Showing the top 50 of 103 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →